VGLL4 inhibits YAP1/TEAD signaling to suppress the epidermal squamous cell carcinoma cancer phenotype
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
VGLL4 inhibits YAP1/TEAD signaling to suppress the epidermal squamous cell carcinoma cancer phenotype
Authors
Keywords
-
Journal
MOLECULAR CARCINOGENESIS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-05-19
DOI
10.1002/mc.23307
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multiple Roles of Vestigial-Like Family Members in Tumor Development
- (2020) Noritaka Yamaguchi Frontiers in Oncology
- Transglutaminase 2 takes center stage as a cancer cell survival factor and therapy target
- (2019) Richard L. Eckert MOLECULAR CARCINOGENESIS
- The YAP1 signaling inhibitors, verteporfin and CA3, suppress the mesothelioma cancer stem cell phenotype
- (2019) Sivaveera Kandasamy et al. MOLECULAR CANCER RESEARCH
- Silencing of COL1A2, COL6A3, and THBS2 inhibits gastric cancer cell proliferation, migration, and invasion while promoting apoptosis through the PI3k-Akt signaling pathway
- (2018) Ran Ao et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- NRP-1 interacts with GIPC1 and α6/β4-integrins to increase YAP1/∆Np63α-dependent epidermal cancer stem cell survival
- (2018) Daniel Grun et al. ONCOGENE
- Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant Mesothelioma
- (2018) Yoshitaka Sekido Cancers
- Conjugated Linoleic Acid Suppresses Myogenic Gene Expression in a Model of Human Muscle Cell Inflammation
- (2018) Amy E. Larsen et al. JOURNAL OF NUTRITION
- NRP-1 interacts with GIPC1 and SYX to activate p38 MAPK signaling and cancer stem cell survival
- (2018) Daniel Grun et al. MOLECULAR CARCINOGENESIS
- A Novel YAP1 Inhibitor Targets CSC-Enriched Radiation-Resistant Cells and Exerts Strong Antitumor Activity in Esophageal Adenocarcinoma
- (2017) Shumei Song et al. MOLECULAR CANCER THERAPEUTICS
- VGLL4 targets a TCF4–TEAD4 complex to coregulate Wnt and Hippo signalling in colorectal cancer
- (2017) Shi Jiao et al. Nature Communications
- Sulforaphane reduces YAP/∆Np63α signaling to reduce cancer stem cell survival and tumor formation
- (2017) Matthew L. Fisher et al. Oncotarget
- VGLL4 Selectively Represses YAP-Dependent Gene Induction and Tumorigenic Phenotypes in Breast Cancer
- (2017) Yinglong Zhang et al. Scientific Reports
- Transglutaminase Interaction with α6/β4-Integrin Stimulates YAP1-Dependent ΔNp63α Stabilization and Leads to Enhanced Cancer Stem Cell Survival and Tumor Formation
- (2016) Matthew L. Fisher et al. CANCER RESEARCH
- VEGF-A acts via neuropilin-1 to enhance epidermal cancer stem cell survival and formation of aggressive and highly vascularized tumors
- (2016) D Grun et al. ONCOGENE
- Transamidase site-targeted agents alter the conformation of the transglutaminase cancer stem cell survival protein to reduce GTP binding activity and cancer stem cell survival
- (2016) C Kerr et al. ONCOGENE
- Identification of COL1A1 and COL1A2 as candidate prognostic factors in gastric cancer
- (2016) Jun Li et al. World Journal of Surgical Oncology
- Epithelial but not stromal expression of collagen alpha-1(III) is a diagnostic and prognostic indicator of colorectal carcinoma
- (2016) Xiao-Qing Wang et al. Oncotarget
- Increased Expression of Several Collagen Genes is Associated with Drug Resistance in Ovarian Cancer Cell Lines
- (2016) Radosław Januchowski et al. Journal of Cancer
- Survival of skin cancer stem cells requires the Ezh2 polycomb group protein
- (2015) Gautam Adhikary et al. CARCINOGENESIS
- Transglutaminase Is Required for Epidermal Squamous Cell Carcinoma Stem Cell Survival
- (2015) M. L. Fisher et al. MOLECULAR CANCER RESEARCH
- Transglutaminase is a tumor cell and cancer stem cell survival factor
- (2015) Richard L. Eckert et al. MOLECULAR CARCINOGENESIS
- Type II transglutaminase stimulates epidermal cancer stem cell epithelial-mesenchymal transition
- (2015) Matthew L. Fisher et al. Oncotarget
- A Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric Cancer
- (2014) Shi Jiao et al. CANCER CELL
- VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex
- (2014) Wenjing Zhang et al. CELL RESEARCH
- Let-7d suppresses growth, metastasis, and tumor macrophage infiltration in renal cell carcinoma by targeting COL3A1 and CCL7
- (2014) Boxing Su et al. Molecular Cancer
- Transglutaminase Regulation of Cell Function
- (2014) Richard L. Eckert et al. PHYSIOLOGICAL REVIEWS
- Downregulation of VGLL4 in the progression of esophageal squamous cell carcinoma
- (2014) Wei Jiang et al. TUMOR BIOLOGY
- The Hippo Effector Yorkie Controls Normal Tissue Growth by Antagonizing Scalloped-Mediated Default Repression
- (2013) Laura M. Koontz et al. DEVELOPMENTAL CELL
- Identification of a Population of Epidermal Squamous Cell Carcinoma Cells with Enhanced Potential for Tumor Formation
- (2013) Gautam Adhikary et al. PLoS One
- Interventions for non-metastatic squamous cell carcinoma of the skin: systematic review and pooled analysis of observational studies
- (2013) L. Lansbury et al. BMJ-British Medical Journal
- Cyr61 increases matrix metalloproteinase-3 expression and cell motility in human oral squamous cell carcinoma cells
- (2012) Jing-Yuan Chuang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes
- (2012) T Mizuno et al. ONCOGENE
- Using FLIM-FRET to Measure Conformational Changes of Transglutaminase Type 2 in Live Cells
- (2012) Nicholas S. Caron et al. PLoS One
- Transglutaminase 2: A molecular Swiss army knife
- (2011) Soner Gundemir et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Taxol Resistance in Breast Cancer Cells Is Mediated by the Hippo Pathway Component TAZ and Its Downstream Transcriptional Targets Cyr61 and CTGF
- (2011) D. Lai et al. CANCER RESEARCH
- The molecular basis that unifies the metabolism, cellular uptake and chemopreventive activities of dietary isothiocyanates
- (2011) Y. Zhang CARCINOGENESIS
- Transglutaminase 2: A multi-tasking protein in the complex circuitry of inflammation and cancer
- (2010) Kapil Mehta et al. BIOCHEMICAL PHARMACOLOGY
- PKC-δ and -η, MEKK-1, MEK-6, MEK-3, and p38-δ Are Essential Mediators of the Response of Normal Human Epidermal Keratinocytes to Differentiating Agents
- (2010) Gautam Adhikary et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now